Medical devices do not stop being monitored once they reach the market. Regulators require companies to keep tracking how a device performs after it is sold and used by real patients. This process is called post-market surveillance, or PMS. It involves collecting safety data, writing reports, and updating regulators on any risks that appear over time. This is where medical […]
Getting a drug or medical device to market is one of the most document-intensive processes in any industry. For startups attempting their first FDA submission, the challenge is not just scientific, it is also about presenting that science in a way the FDA expects and accepts. This is exactly why a growing number of early-stage pharma, biotech, and medical […]
The FDA approved 50 new drugs in 2024, compared to roughly 35 in 2023, signaling steady growth in drug approvals. This has led to an increase in demand for medical writing services. High-quality medical writing is one of the most critical foundations of clinical research. Every protocol, clinical study report, regulatory submission and safety document must […]
Submission of inadequate documentation can lead to delays and postponements by months or longer. Today, the success of a new drug depends not just on the quality but also on the precision and clarity of the documentation. Strict regulatory authorities such as the US FDA, EMA, and CDSCO evaluate hundreds of new products every year, […]
